Oragenics (OGEN) Return on Sales (2010 - 2023)
Oragenics' (OGEN) quarterly Return on Sales came in at 5.49% in Q4 2023, down 440.0% YoY from 1.61% in Q4 2022, and down 103.47% on a QoQ basis from 2.7% in Q3 2023.
Oragenics (OGEN) Return on Sales (2010 - 2023) Analysis & Trends
Oragenics (OGEN) has 8 years of Return on Sales data on file, last reported at 5.49% in Q4 2023.
- Quarterly Return on Sales fell 440.0% year-over-year to 5.49% in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 5.49% (down 440.0% YoY) and the FY2023 annual result came in at 5.49%, down 463.0% from the prior year.
- Return on Sales fell to 5.49% in Q4 2023, from 2.7% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.45% in Q3 2022 to a low of 5.49% in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Oragenics | 2.31 Mn | 2.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -5.49% |
| Sep 30, 2023 | -2.70% |
| Jun 30, 2023 | -2.32% |
| Mar 31, 2023 | -1.67% |
| Dec 31, 2022 | -1.09% |
| Sep 30, 2022 | -0.45% |
| Jun 30, 2022 | -1.18% |
| Mar 31, 2022 | -3.04% |
| Sep 30, 2015 | -0.05% |
| Jun 30, 2015 | -0.05% |
| Mar 31, 2015 | -0.06% |
| Dec 31, 2014 | -0.06% |
| Sep 30, 2014 | -0.05% |
| Jun 30, 2014 | -0.06% |
| Mar 31, 2014 | -0.08% |
| Dec 31, 2013 | -0.07% |
| Sep 30, 2013 | -0.37% |
| Jun 30, 2013 | -0.12% |
| Mar 31, 2013 | -0.09% |
| Dec 31, 2012 | -0.05% |